Author

Pallavi Mishra

Observed name: Pallavi S Mishra

Institution: Glenmark Pharmaceuticals (India)

Observed institution: Glenmark Pharmaceuticals (India)

ORCID: 0009-0003-4303-9837

Observed ORCID: 0009-0003-4303-9837

OpenAlex ID: A5125443380

Clotrimazole Dusting Powder Improves Patient-Reported Outcomes in Patients with Dermatophytosis: Real World Analysis from India

2026 · Rachna Jagia, Pallavi Mishra, et al. · Journal of Dermatology Research · 2

Assessing the Impact of Dermatophytosis on Quality of Life Using the Dermatology Life Quality Index: A Real-World Cross-Sectional Study From India

2026 · Priyanka Singh, Manjunath Shenoy, et al. · Cureus · 1

Indian dermatological experts’ opinion on clotrimazole dusting powder in superficial fungal infection

2026 · Manjunath Shenoy, Anil Ganjoo, et al. · International Journal of Research in Dermatology

Real World Effectiveness and Safety of Super Bioavailable Itraconazole for Glabrous Dermatophytosis in India: A Multi Centre Retrospective Analysis

2026 · Kapil Chandra, Pallavi Mishra, et al. · Journal of Dermatology Research

A drug utilization study to evaluate the prescribing pattern of clotrimazole dusting powder in dermatophytosis

2026 · Deepak Jakhar, Pallavi Mishra, et al. · International Journal of Research in Dermatology

Works count: 5

Citation count: 3

H-index: 1

I10-index: